Literature DB >> 14582143

Polymorphism analysis of HOPA: a candidate gene for schizophrenia.

Harinder K Sandhu1, Mitul Sarkar, Beth M Turner, Tom H Wassink, Robert A Philibert.   

Abstract

HOPA is a 25 kb Xq13 gene that codes for a member of the thyroid receptor co-activator protein (TRAP) family of nuclear receptor co-activators. In our prior research, polymorphisms in the opposite paired (Opa) domain of HOPA have been associated with a syndrome of aberrant behavior, most prominently psychosis, and hypothyroidism. These Opa domain polymorphisms are intriguing because subsequent research has demonstrated that changes in the Opa domain of the C. elegans orthologue of HOPA results in altered neurogenesis and release of transcriptional suppression. In an effort to determine whether other allelic polymorphisms in this gene exist and may potentially contribute to increased susceptibility to neuropsychiatric illness, we have performed single stranded conformational polymorphism (SSCP) analysis of all 45 exons and each of the two potential promoter regions of HOPA using DNA from a panel of patients with psychosis. We found a rare promoter polymorphism in an individual with schizoaffective disorder and extremely low thyroid stimulating hormone (TSH). The most common exonic polymorphism in HOPA is the previously demonstrated HOPA(12 bp) polymorphism. Transmission disequilibrium analysis of the HOPA(12 bp) polymorphism showed segregation with affected status in six of eight instances. We suggest that this evidence supports previous associations of HOPA(12 bp) with a broad range of neuropsychiatric illness and conclude that further studies of this uncommon polymorphism are merited. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14582143     DOI: 10.1002/ajmg.b.20019

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  5 in total

1.  The Sex Chromosome Hypothesis of Schizophrenia: Alive, Dead, or Forgotten? A Commentary and Review.

Authors:  William K Bache; Lynn E DeLisi
Journal:  Mol Neuropsychiatry       Date:  2018-08-20

2.  Sex-specific rates of transmission of psychosis in the New England high-risk family study.

Authors:  Jill M Goldstein; Sara Cherkerzian; Larry J Seidman; Tracey L Petryshen; Garrett Fitzmaurice; Ming T Tsuang; Stephen L Buka
Journal:  Schizophr Res       Date:  2011-02-18       Impact factor: 4.939

3.  JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex.

Authors:  Wei-Wei Gao; Rong-Quan Xiao; Wen-Juan Zhang; Yi-Ren Hu; Bing-Ling Peng; Wen-Juan Li; Yao-Hui He; Hai-Feng Shen; Jian-Cheng Ding; Qi-Xuan Huang; Tian-Yi Ye; Ying Li; Zhi-Ying Liu; Rong Ding; Michael G Rosenfeld; Wen Liu
Journal:  Mol Cell       Date:  2018-04-05       Impact factor: 17.970

Review 4.  Sex chromosome abnormalities and psychiatric diseases.

Authors:  Xinzhu Zhang; Jian Yang; Yuhong Li; Xin Ma; Rena Li
Journal:  Oncotarget       Date:  2017-01-17

Review 5.  Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.